申请人:——
公开号:US20040014766A1
公开(公告)日:2004-01-22
The present invention is a 1,3,8 substituted xanthine derivative of formula I
1
or a pharmaceutically acceptable salt thereof, wherein R
1
, R
2
and R
3
are as defined in the specification.
Compounds of formula I and pharmaceutically acceptable salts or prodrugs thereof show activity as modulators of gluconeogenesis.
本发明是一种具有如下结构的1,3,8取代黄嘌呤衍生物(I1)或其药学上可接受的盐,其中R1、R2和R3如规范中定义。公式I的化合物及其药学上可接受的盐或前药显示出作为糖异生调节剂的活性。